Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2025-12-24 @ 9:06 PM
NCT ID: NCT02193204
Eligibility Criteria: Inclusion Criteria: * ADs: Male and females, aged 18-50 years, meeting current DSM-IV criteria for alcohol dependence consuming more than 25 drinks / week. * SDs: Male and females, aged 18-50 years. Must not meet either current or lifetime DSM-IV criteria for alcohol/drug abuse. They must have demonstrated weekly alcohol use over the past year but no more than 25 drinks / month with no occasion of binge drinking (5 or more drinks-men; 4 or more -women). * ADs and SDs must self-report depression ratings at levels to match one of the two following groups: a) a score of 20 or above in the Center for Epidemiologic Studies - Depression Scale (CES-D), or b) a score between 3 -20 on the CES-D * Weekly alcohol use as documented by positive urine toxicology screens (AD only). * Good health as verified by screening examinations and medical and screening * Able to read English and complete study evaluations. * All participants must voluntarily provide informed consent and sign the informed consent document. Exclusion Criteria: * Meeting current criteria for dependence on another psychoactive substance, excluding nicotine. * Having any current Axis I psychiatric disorders and requiring treatment/medication for these conditions. * Having significant underlying medical conditions requiring medication. * Women who are pregnant or nursing.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 50 Years
Study: NCT02193204
Study Brief:
Protocol Section: NCT02193204